Gates Foundation gives Duke $24.6M for HIV vaccine research

The Bill and Melinda Gates Foundation has handed Duke University researchers $24.6 million over five years for work on developing a vaccine to prevent HIV. The funding is part of a larger $37.2 million gift to the university. The money will support a "global lab program to monitor antibody immune response," which Duke AIDS lab director Dr. David Montefiori says will give researchers insights on how to design an effective HIV vaccine. Report

Suggested Articles

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

Behind the under-pressure blockbuster Prevnar 13 are several pipeline vaccines Pfizer hopes will propel future growth.